Meyka AI API is live for developers.Start building.
Advertisement
Raia Drogasil S.A.

Raia Drogasil S.A. (RADLY) Stock Overview

Explore Raia Drogasil S.A.’s financial performance, market position, analyst ratings, and future outlook.

RADLYPNK
HealthcareMedical - Pharmaceuticals
$3.44
$0.09(2.62%)
U.S. Market opens in 47h 28m
Advertisement

Raia Drogasil S.A. (RADLY)

Meyka AI Score

Z

Key Financials

Market Cap6B
P/E Ratio22.52
EPS (TTM)$0.16
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$4.76
3 Months$6.10
1 Year Target$2.73

RADLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Raia Drogasil S.A. (RADLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.52 and a market capitalization of 6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.62%
5-Day Change
-9.23%
1-Month Change
-25.54%
3-Month Change
-25.54%
6-Month Change
-15.48%
Year-to-Date (YTD) Change
-26.02%
1-Year Change
13.91%
3-Year Change
-41.79%
5-Year Change
-38.13%
All-Time (Max) Change
-10.42%

Contact Information

55 11 3769 5678
Av. Corifeu de Azevedo Marques, 3097, São Paulo, SP, 05.339-900

Company Facts

66,275 Employees
IPO DateJul 19, 2016
CountryBR
Actively Trading

Frequently Asked Questions